Modulation of Cerebral Blood Flow Using Iron Chelators "DFO"


Phase 0 Results N/A

Summary of Purpose

The purpose of this study is determine if the iron chelator, desferrioxamine can increase blood levels of hypoxia-inducible transcription factor 1 (HIF-1 protein) and to see if there is a corresponding increase in blood flow to the brain.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 January 2015.

1 Mar 2008 31 May 2011 1 Jun 2012 1 Dec 2014 1 Jan 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Intervention: Crossover Assignment


Not available